{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["adjunct therapy", "isoniazid", "mc2155", "stress tolerance", "targeted metabolomics", "tuberculosis"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "39081888", "DateRevised": {"Year": "2024", "Month": "08", "Day": "01"}, "Article": {"Language": ["eng"], "ELocationID": ["1429027", "10.3389/fmicb.2024.1429027"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "16"}], "Journal": {"ISSN": "1664-302X", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2024"}}, "Title": "Frontiers in microbiology", "ISOAbbreviation": "Front Microbiol"}, "ArticleTitle": "Robust anti-tubercular profile of <i>Solanum virginianum</i> extract in enhancing isoniazid bioavailability and curtailing stress tolerance in <i>Mycobacterium smegmatis</i>.", "Pagination": {"StartPage": "1429027", "MedlinePgn": "1429027"}, "Abstract": {"AbstractText": ["The formidable survival mechanisms employed by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), combined with the low bioavailability of anti-tubercular drugs and their associated hepatotoxicity, worsen tuberculosis management. Traditional medicinal plants offer potential solutions to these challenges. This study focuses on exploring the anti-tubercular potential of <i>Solanum virginianum</i> against <i>Mycobacterium smegmatis</i>, <i>mc<sup>2</sup>155</i>.", "HPTLC and UHPLC phytochemically characterized the hydro-methanolic extract of <i>Solanum virginianum</i> (SVE). SVE curtails the growth and viability of <i>mc<sup>2</sup>155</i> under normal and <i>in vitro</i> stress conditions. The compromised cell wall integrity of <i>mc<sup>2</sup>155</i> with SVE is depicted through scanning electron microscopy (SEM) while EtBr permeability assays and TLC-based comparative changes in lipids extraction addressed the integrity of the cell wall. Furthermore, SVE augmented the susceptibility of <i>mc<sup>2</sup>155</i> towards Isoniazid (INH) through enhanced bioavailability. Adjunct treatment of SVE with INH demonstrated a markedly reduced survival of the intracellular bacilli. The study also uncovered the hepatoprotective potential of SVE in HepG2 cells.", "This research paves the way for deeper exploration into the potential of <i>Solanum virginianum</i> against virulent <i>Mtb</i> strains, emphasizing over the significance of traditional medicinal plants in tuberculosis treatment. Collectively, the findings suggest SVE as a potent candidate for independent or adjunct anti-tubercular therapy."], "CopyrightInformation": "Copyright \u00a9 2024 Balkrishna, Joshi, Kabdwal, Tomer, Lochab and Varshney."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Patanjali Yog Peeth (UK) Trust, Glasgow, United Kingdom."}, {"Identifier": [], "Affiliation": "Vedic Acharya Samaj Foundation, Inc., Groveland, FL, United States."}], "LastName": "Balkrishna", "ForeName": "Acharya", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India."}], "LastName": "Joshi", "ForeName": "Monali", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India."}], "LastName": "Kabdwal", "ForeName": "Manisha", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India."}], "LastName": "Tomer", "ForeName": "Meenu", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India."}], "LastName": "Lochab", "ForeName": "Savita", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India."}, {"Identifier": [], "Affiliation": "Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India."}], "LastName": "Varshney", "ForeName": "Anurag", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Microbiol", "NlmUniqueID": "101548977", "ISSNLinking": "1664-302X"}, "CoiStatement": "AB is an honorary trustee in Divya Yog Mandir Trust, which governs Divya Pharmacy, Haridwar. In addition, he holds an honorary managerial position in Patanjali Ayurved Ltd., Haridwar, India and is employed by Vedic Acharya Samaj Foundation, Inc. Divya Pharmacy and Patanjali Ayurved Ltd., commercially manufacture and sell several Ayurvedic products. MJ, MK, MT, SL, and AV have been employed at Patanjali Research Foundation which is governed by Patanjali Research Foundation Trust (PRFT), Haridwar, Uttarakhand, India. PRFT is an independent not-for-profit organization."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ansari M. A., Shoaib S., Alomary M. N., Ather H., Ansari S. M. A., Hani U., et al. . (2023). Deciphering the emerging role of phytocompounds: implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage. J. Infect. Public Health 16, 1443\u20131459. doi: 10.1016/j.jiph.2023.07.016, PMID:", "ArticleIdList": ["10.1016/j.jiph.2023.07.016", "37523915"]}, {"Citation": "Anwer T., Alruwaili M. N., Alshahrani S., Alqahtani S. S., Jali A., Ahmed R. A., et al. . (2023). Hepatoprotective potential of diosmin against hepatotoxic effect of isoniazid and rifampin in wistar rats. Hum. Exp. Toxicol. 42:96032712211491. doi: 10.1177/09603271221149199", "ArticleIdList": ["10.1177/09603271221149199", "36592122"]}, {"Citation": "Bagcchi S. (2023). WHO\u2019s global tuberculosis report 2022. Lancet Microbe 4:e20. doi: 10.1016/S2666-5247(22)00359-7, PMID:", "ArticleIdList": ["10.1016/S2666-5247(22)00359-7", "36521512"]}, {"Citation": "Balkrishna A., Rastogi S., Kharayat B., Tomer M., Varshney Y., Singh K., et al. . (2022). Anu taila, an herbal nasal drop, suppresses mucormycosis by regulating host TNF-\u03b1 response and fungal ergosterol biosynthesis. J. Appl. Microbiol. 132, 3355\u20133374. doi: 10.1111/jam.15451, PMID:", "ArticleIdList": ["10.1111/jam.15451", "35025137"]}, {"Citation": "Borges A., Saavedra M. J., Sim\u00f5es M. (2015). Insights on antimicrobial resistance, biofilms and the use of phytochemicals as new antimicrobial agents. Curr. Med. Chem. 22, 2590\u20132614. doi: 10.2174/0929867322666150530210522, PMID:", "ArticleIdList": ["10.2174/0929867322666150530210522", "26028341"]}, {"Citation": "Brennan P. J., Heifets M., Ullom B. P. (1982). Thin-layer chromatography of lipid antigens as a means of identifying nontuberculous mycobacteria. J. Clin. Microbiol. 15, 447\u2013455. doi: 10.1128/jcm.15.3.447-455.1982, PMID:", "ArticleIdList": ["10.1128/jcm.15.3.447-455.1982", "PMC272116", "7076818"]}, {"Citation": "Choudhary N., Khajuria V., Gillani Z., Tandon V., Arora E. (2014). Effect of Carum carvi, a herbal bioenhancer on pharmacokinetics of antitubercular drugs: A study in healthy human volunteers. Perspect Clin. Res. 5:80., PMID:", "ArticleIdList": ["PMC3980549", "24741485"]}, {"Citation": "Darvin S. S., Esakkimuthu S., Toppo E., Balakrishna K., Paulraj M. G., Pandikumar P., et al. . (2018). Hepatoprotective effect of lawsone on rifampicin-isoniazid induced hepatotoxicity in in vitro and in vivo models. Environ. Toxicol. Pharmacol. 61, 87\u201394. doi: 10.1016/j.etap.2018.05.006", "ArticleIdList": ["10.1016/j.etap.2018.05.006", "29859372"]}, {"Citation": "Ezhilarasan D. (2023). Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms. Drug Metab. Rev. 55, 239\u2013253. doi: 10.1080/03602532.2023.2215478, PMID:", "ArticleIdList": ["10.1080/03602532.2023.2215478", "37218081"]}, {"Citation": "Gautam S., Qureshi K. A., Jameel Pasha S. B., Dhanasekaran S., Aspatwar A., Parkkila S., et al. . (2023). Medicinal plants as therapeutic alternatives to combat Mycobacterium tuberculosis: a comprehensive review. Antibiotics 12:541. doi: 10.3390/antibiotics12030541, PMID:", "ArticleIdList": ["10.3390/antibiotics12030541", "PMC10044459", "36978408"]}, {"Citation": "Gonz\u00e1lez L. T., Minsky N. W., Espinosa L. E. M., Aranda R. S., Meseguer J. P., P\u00e9rez P. C. (2017). In vitro assessment of hepatoprotective agents against damage induced by acetaminophen and CCl4. BMC Complement. Altern. Med. 17:39. doi: 10.1186/s12906-016-1506-1, PMID:", "ArticleIdList": ["10.1186/s12906-016-1506-1", "PMC5234107", "28086854"]}, {"Citation": "Kashyap A., Singh P. K., Silakari O. (2018). Mechanistic investigation of resistance via drug-inactivating enzymes in Mycobacterium tuberculosis. Drug Metab. Rev. 50, 448\u2013465. doi: 10.1080/03602532.2018.1533966, PMID:", "ArticleIdList": ["10.1080/03602532.2018.1533966", "30343607"]}, {"Citation": "Liu Q., Garner P., Wang Y., Huang B., Smith H. (2008). Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies. BMC Public Health 8:365. doi: 10.1186/1471-2458-8-365, PMID:", "ArticleIdList": ["10.1186/1471-2458-8-365", "PMC2576232", "18939987"]}, {"Citation": "Mangwani N., Singh P. K., Kumar V. (2020). Medicinal plants: adjunct treatment to tuberculosis chemotherapy to prevent hepatic damage. J. Ayurveda Integr. Med. 11, 522\u2013528. doi: 10.1016/j.jaim.2019.02.004, PMID:", "ArticleIdList": ["10.1016/j.jaim.2019.02.004", "PMC7772497", "31679802"]}, {"Citation": "Merkl R., Hr\u00e1dkov\u00e1 I., Filip V., \u0160midrkal J. (2010). Antimicrobial and antioxidant properties of phenolic acids alkyl esters. Czech J. Food Sci. 28, 275\u2013279. doi: 10.17221/132/2010-CJFS", "ArticleIdList": ["10.17221/132/2010-CJFS"]}, {"Citation": "Miao M., Xiang L. (2020). Pharmacological action and potential targets of chlorogenic acid. Adv. Pharmacol. 87, 71\u201388. doi: 10.1016/bs.apha.2019.12.002", "ArticleIdList": ["10.1016/bs.apha.2019.12.002", "32089239"]}, {"Citation": "Mohamadi N., Sharififar F., Pournamdari M., Ansari M. (2018). A review on biosynthesis, analytical techniques, and pharmacological activities of Trigonelline as a plant alkaloid. J. Diet Suppl. 15, 207\u2013222. doi: 10.1080/19390211.2017.1329244, PMID:", "ArticleIdList": ["10.1080/19390211.2017.1329244", "28816550"]}, {"Citation": "Nageswari A. D., Rajanandh M. G., Uday M. K., Nasreen R. A., Pujitha R. J., Prathiksha R. R., et al. . (2018). Effect of rifampin with bio-enhancer in the treatment of newly diagnosed sputum positive pulmonary tuberculosis patients: A double-center study. J. Clin. Tubercul. Mycobact. Dis. 12, 73\u201377.", "ArticleIdList": ["PMC6830140", "31720402"]}, {"Citation": "Patra A. K. (2012). \u201cAn overview of antimicrobial properties of different classes of phytochemicals\u201d in Dietary phytochemicals and microbes. ed. Patra A. K. (Netherlands, Dordrecht: Springer; ), 1\u201332."}, {"Citation": "Pieters J. (2008). Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 3, 399\u2013407. doi: 10.1016/j.chom.2008.05.006", "ArticleIdList": ["10.1016/j.chom.2008.05.006", "18541216"]}, {"Citation": "Qin W., Guan D., Ma R., Yang R., Xing G., Shi H., et al. . (2017). Effects of trigonelline inhibition of the Nrf2 transcription factor in vitro on Echinococcus granulosus. Acta Biochim. Biophys. Sin. Shanghai 49, 696\u2013705. doi: 10.1093/abbs/gmx067, PMID:", "ArticleIdList": ["10.1093/abbs/gmx067", "28810706"]}, {"Citation": "Raja W., Nosalova G., Ghosh K., Sivova V., Nosal S., Ray B. (2014). In vivo antitussive activity of a pectic arabinogalactan isolated from Solanum virginianum L. in Guinea pigs. J. Ethnopharmacol. 156, 41\u201346. doi: 10.1016/j.jep.2014.08.012, PMID:", "ArticleIdList": ["10.1016/j.jep.2014.08.012", "25150526"]}, {"Citation": "Riaz A., Rasul A., Hussain G., Zahoor M. K., Jabeen F., Subhani Z., et al. . (2018). Astragalin: a bioactive phytochemical with potential therapeutic activities. Adv. Pharmacol. Sci. 2018, 1\u201315. doi: 10.1155/2018/9794625", "ArticleIdList": ["10.1155/2018/9794625", "PMC5954929", "29853868"]}, {"Citation": "Rodrigues L., Wagner D., Viveiros M., Sampaio D., Couto I., Vavra M., et al. . (2008). Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J. Antimicrob. Chemother. 61, 1076\u20131082. doi: 10.1093/jac/dkn070, PMID:", "ArticleIdList": ["10.1093/jac/dkn070", "18310137"]}, {"Citation": "Sachin B. S., Sharma S. C., Sethi S., Tasduq S. A., Tikoo M. K., Tikoo A. K., et al. . (2007). Herbal modulation of drug bioavailability: enhancement of rifampicin levels in plasma by herbal products and a flavonoid glycoside derived from Cuminum cyminum. Phyther. Res. 21, 157\u2013163.", "ArticleIdList": ["17128432"]}, {"Citation": "Salehi B., Venditti A., Sharifi-Rad M., Kr\u0119giel D., Sharifi-Rad J., Durazzo A., et al. . (2019). The therapeutic potential of Apigenin. Int. J. Mol. Sci. 20:1305. doi: 10.3390/ijms20061305, PMID:", "ArticleIdList": ["10.3390/ijms20061305", "PMC6472148", "30875872"]}, {"Citation": "Samal J. (2016). Ayurvedic management of pulmonary tuberculosis: a systematic review. J. Intercult. Ethnopharmacol. 5, 86\u201391. doi: 10.5455/jice.20151107020621", "ArticleIdList": ["10.5455/jice.20151107020621", "PMC4805153", "27069721"]}, {"Citation": "Sharma R., Muthu S. A., Agarwal M., Mehto N. K., Pahuja I., Grover A., et al. . (2023). Atosiban and Rutin exhibit anti-mycobacterial activity - an integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis targeting its essential enzyme HemD. Int. J. Biol. Macromol. 253:127208. doi: 10.1016/j.ijbiomac.2023.127208, PMID:", "ArticleIdList": ["10.1016/j.ijbiomac.2023.127208", "37816464"]}, {"Citation": "Sparks I. L., Derbyshire K. M., Jacobs W. R., Morita Y. S. (2023). Mycobacterium smegmatis: the vanguard of mycobacterial research. J. Bacteriol. 205:e0033722. doi: 10.1128/jb.00337-22, PMID:", "ArticleIdList": ["10.1128/jb.00337-22", "PMC9879119", "36598232"]}, {"Citation": "Taneja N. K., Tyagi J. S. (2007). Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis. J. Antimicrob. Chemother. 60, 288\u2013293. doi: 10.1093/jac/dkm207", "ArticleIdList": ["10.1093/jac/dkm207", "17586560"]}, {"Citation": "Tella J. O., Adekoya J. A., Ajanaku K. O. (2022). Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review. R. Soc. Open Sci. 9:220013. doi: 10.1098/rsos.220013, PMID:", "ArticleIdList": ["10.1098/rsos.220013", "PMC9174711", "35706676"]}, {"Citation": "The Lancet Public Health (2023). Taking tuberculosis out of the shadows. Lancet Public Health 8:e247. doi: 10.1016/S2468-2667(23)00063-4, PMID:", "ArticleIdList": ["10.1016/S2468-2667(23)00063-4", "PMC10036124", "36965975"]}, {"Citation": "Tizzano B., Dallenga T. K., Utpatel C., Behrends J., Homolka S., Kohl T. A., et al. . (2021). Survival of hypoxia-induced dormancy is not a common feature of all strains of the Mycobacterium tuberculosis complex. Sci. Rep. 11:2628. doi: 10.1038/s41598-021-81223-6, PMID:", "ArticleIdList": ["10.1038/s41598-021-81223-6", "PMC7846770", "33514768"]}, {"Citation": "Yang X., Lan W., Xie J. (2022). Antimicrobial and anti-biofilm activities of chlorogenic acid grafted chitosan against Staphylococcus aureus. Microb. Pathog. 173:105748. doi: 10.1016/j.micpath.2022.105748", "ArticleIdList": ["36064104"]}]}], "History": [{"Year": "2024", "Month": "5", "Day": "7"}, {"Year": "2024", "Month": "6", "Day": "7"}, {"Year": "2024", "Month": "7", "Day": "31", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "7", "Day": "31", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "7", "Day": "31", "Hour": "4", "Minute": "25"}, {"Year": "2024", "Month": "7", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["39081888", "PMC11286421", "10.3389/fmicb.2024.1429027"]}}]}